Treatment methods based on microcompetition for a limiting GABP complex
OwnerHanan Polanskyinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerHanan Polanskyinventor
Estimating the term…
Microcompetition for GABP between a foreign polynucleotide and a cellular GABP regulated gene is a risk factor associated with chronic disease such as obesity, cancer, atherosclerosis, stroke, osteoarthritis, diabetes, asthma, and other autoimmune diseases. The invention uses this novel discovery to present methods for the treatment of these chronic diseases. The methods are based on modifying such microcompetition, or the effect of such microcompetition on the cell. For instance, treatment may modify the cellular copy number of the foreign polynucleotide, change the rate of complex formation between GABP and either the foreign polynucleotide or the cellular GABP regulated gene, vary the expression of the cellular GABP regulated gene, or manipulate the activity of the gene product of the cellular GABP regulated gene. The invention also presents methods for treatment of chronic diseases resulting from other foreign polynucleotide-type disruptions.
A method for the treatment of a chronic disease, comprising administration to an animal or human subject an effective amount of an agent that modifies microcompetition for GABP between a polynucleotide natural to said subject and a polynucleotide foreign to said subject.
A method for the treatment of a chronic disease, comprising administration to an animal or human subject an effective amount of an agent that modifies formation of a complex that includes GABP and a polynucleotide foreign to said subject.
A method for the treatment of a chronic disease, comprising administration to an animal or human subject an effective amount of an agent that modifies formation of a complex that includes GABP and a polynucleotide natural to said subject.
A method for the treatment of a chronic disease, comprising administration to an animal or human subject an effective amount of an agent that modifies the copy number of a GABP polynucleotide foreign to said subject, in a said subject cell.
A method for the treatment of a chronic disease, comprising administration to an animal or human subject an effective amount of an agent that modifies the copy number of a latent GABP polynucleotide foreign to said subject, in a said subject cell.
A method for the treatment of a chronic disease, comprising administration to an animal or human subject an effective amount of an agent which performs a function selected from a group consisting of:
A method for the treatment of a chronic disease, comprising administration to an animal or human subject an effective amount of an agent which performs a function selected from a group consisting of:
A method for the treatment of a chronic disease, comprising administration to an animal or human subject an effective amount of an agent which performs a function selected from a group consisting of:
Dependencies are inferred from the claim text.